185 related articles for article (PubMed ID: 33960283)
21. Network models of prostate cancer immune microenvironments identify ROMO1 as heterogeneity and prognostic marker.
Wang L; Liu X; Liu Z; Wang Y; Fan M; Yin J; Zhang Y; Ma Y; Luo J; Li R; Zhao X; Zhang P; Zhao L; Fan J; Chen Y; Lu W; Song X
Sci Rep; 2022 Jan; 12(1):192. PubMed ID: 34996995
[TBL] [Abstract][Full Text] [Related]
22. Application of weighted gene co‑expression network analysis to explore the potential diagnostic biomarkers for colorectal cancer.
Qin L; Zeng J; Shi N; Chen L; Wang L
Mol Med Rep; 2020 Jun; 21(6):2533-2543. PubMed ID: 32323816
[TBL] [Abstract][Full Text] [Related]
23. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer.
Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X
Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687
[TBL] [Abstract][Full Text] [Related]
24. A prognostic model based on tumor microenvironment and immune cell in colorectal cancer.
Lin Y; Chen Y; Gan L; Li Z; Shen F
Scand J Gastroenterol; 2024 Mar; 59(3):304-315. PubMed ID: 37978827
[TBL] [Abstract][Full Text] [Related]
25. Identification of genes related to ribosomal proteins in colorectal cancer: exploring their potential as biomarkers, prognostic indicators, and therapeutic targets.
Salehinia N; Mohammad Al-Mosawi AK; Al-Moussawi DK; Sadeghi ES; Zamani A; Mahdevar M
Mol Biol Rep; 2024 Apr; 51(1):576. PubMed ID: 38664314
[TBL] [Abstract][Full Text] [Related]
26. Construction of a ceRNA network of hub genes affecting immune infiltration in ovarian cancer identified by WGCNA.
Su R; Jin C; Zhou L; Cao Y; Kuang M; Li L; Xiang J
BMC Cancer; 2021 Aug; 21(1):970. PubMed ID: 34461858
[TBL] [Abstract][Full Text] [Related]
27. Identification of key genes in colorectal cancer diagnosis by co-expression analysis weighted gene co-expression network analysis.
Mortezapour M; Tapak L; Bahreini F; Najafi R; Afshar S
Comput Biol Med; 2023 May; 157():106779. PubMed ID: 36931200
[TBL] [Abstract][Full Text] [Related]
28. Budding and tumor-infiltrating lymphocytes - combination of both parameters predicts survival in colorectal cancer and leads to new prognostic subgroups.
Lang-Schwarz C; Melcher B; Haumaier F; Lang-Schwarz K; Rupprecht T; Vieth M; Sterlacci W
Hum Pathol; 2018 Sep; 79():160-167. PubMed ID: 29787819
[TBL] [Abstract][Full Text] [Related]
29. Tumor infiltrating lymphocytes associated competitive endogenous RNA networks as predictors of outcome in hepatic carcinoma based on WGCNA analysis.
He Y; Xu R; Peng L; Hu X
PLoS One; 2021; 16(7):e0254829. PubMed ID: 34324544
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis.
Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L
World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034
[TBL] [Abstract][Full Text] [Related]
31. Identification of four novel hub genes as monitoring biomarkers for colorectal cancer.
Luo D; Yang J; Liu J; Yong X; Wang Z
Hereditas; 2022 Jan; 159(1):11. PubMed ID: 35093172
[TBL] [Abstract][Full Text] [Related]
32. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
[TBL] [Abstract][Full Text] [Related]
33. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
[TBL] [Abstract][Full Text] [Related]
34. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
[TBL] [Abstract][Full Text] [Related]
35. Identification of a five-gene signature with prognostic value in colorectal cancer.
Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
[TBL] [Abstract][Full Text] [Related]
36. Differential gene expression of tumor-infiltrating CD4
Sasidharan Nair V; Saleh R; Taha RZ; Toor SM; Murshed K; Ahmed AA; Kurer MA; Abu Nada M; Al Ejeh F; Elkord E
Oncoimmunology; 2020 Sep; 9(1):1825178. PubMed ID: 33101776
[TBL] [Abstract][Full Text] [Related]
37. Identification of biomarkers related to CD8
Lin J; Yu M; Xu X; Wang Y; Xing H; An J; Yang J; Tang C; Sun D; Zhu Y
Aging (Albany NY); 2020 Feb; 12(4):3694-3712. PubMed ID: 32081834
[TBL] [Abstract][Full Text] [Related]
38. Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.
Narayanan S; Kawaguchi T; Yan L; Peng X; Qi Q; Takabe K
Ann Surg Oncol; 2018 Aug; 25(8):2323-2331. PubMed ID: 29770915
[TBL] [Abstract][Full Text] [Related]
39. Exploration and validation of the effects of robust co-expressed immune-related genes on immune infiltration patterns and prognosis in laryngeal cancer.
Zeng H; Huang Y; Chen L; Li H; Ma X
Int Immunopharmacol; 2020 Aug; 85():106622. PubMed ID: 32485354
[TBL] [Abstract][Full Text] [Related]
40. Identification of a novel macrophage-related prognostic signature in colorectal cancer.
Lin D; Zheng T; Huang S; Liu R; Guan S; Zhang Z
Sci Rep; 2024 Feb; 14(1):2767. PubMed ID: 38307957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
